Alain Algazi

2 clinical trials · Sponsor

Record	Firm	Date
Durvalumab and Epacadostat for Treatment of Unresectable, Recurrent, or Metastatic Epstein-Barr Virus Positive Nasopharyngeal Cancer (NCT04231864)	Alain Algazi	2020-12-01
Preoperative Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck (NCT03708224)	Alain Algazi	2019-03-08

Every clearance here is in the API, with alerts when new ones post.